Science
Here's How Insulet Could Continue to Reward Shareholders
Some traders like to buy dips, but I like to buy strength.
World's Biggest Unicorn Investor Is Acting Soggy
Softbank's weakness is another sign of slowing economic conditions and restrictive monetary conditions.
If You're in Neurocrine Biosciences Consider Getting Out: Here's Why
Let's check the charts and indicators.
Does Intellia Therapeutics Stock Have Good Genes?
Let's check on the charts and indicators of the cutting-edge CRISPR editing company.
Lululemon Sinks on Lower Guidance: Here's Where the Stock Could Be Headed Next
Let's delve into the charts and see what's in store for the shares.
What's Next for AbbVie Now That It Reached Our Price Target?
Let's review the charts and indicators.
Replimune Breaks Out: Could Rise 30% From Here
Let's check out the charts and indicators of this biotech name.
Struggling 3M Needs to Form a Base, but Lowered Guidance Won't Help
The diversified technology giant has been bearish for months and is likely to remain so after reducing its full-year revenue and profit forecasts.
Bearish Bets: 3 Stocks You Should Think About Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
My Strategy to Buy Beam Therapeutics
Let's look at the charts and indicators.